Monogram Orthopaedics Inc... (MGRM)
Bid | 2.47 |
Market Cap | 101.71M |
Revenue (ttm) | n/a |
Net Income (ttm) | -16.01M |
EPS (ttm) | -0.5 |
PE Ratio (ttm) | -5.7 |
Forward PE | -6.51 |
Analyst | Strong Buy |
Ask | 2.91 |
Volume | 80,267 |
Avg. Volume (20D) | 658,807 |
Open | 2.73 |
Previous Close | 2.66 |
Day's Range | 2.66 - 2.86 |
52-Week Range | 1.92 - 4.21 |
Beta | 0.41 |
About MGRM
undefined
Analyst Forecast
According to 0 analyst ratings, the average rating for MGRM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts
1 month ago · seekingalpha.com
Monogram Technologies Inc. (MGRM) Q1 2025 Earnings Call TranscriptMonogram Technologies Inc. (NASDAQ:MGRM ) Q1 2025 Earnings Conference Call May 14, 2025 4:30 PM ET Company Participants Larry Holub - Investor Relations Noel Knape - Chief Financial Officer Ben Sexson...

2 months ago · accessnewswire.com
Monogram Technologies Partners with Urvin to Launch an Exclusive, Verified Shareholder CommunityAUSTIN, TX / ACCESS Newswire / March 20, 2025 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial ...

3 months ago · accessnewswire.com
Monogram Technologies Announces FDA 510(k) Clearance for the Monogram mBôsTM TKA SystemMonogram May Market the Monogram mBôs™ TKA System, Subject to the Requirements of the Federal Food, Drug, and Cosmetic Act (the Act). The Company is Preparing for Commercialization and Evaluating Stra...